Good Growth Capital — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesPhiladelphia, US
Rui Jing Jiang(Ms. Jiang is the Chief Executive Officer of the Issuer.)inPaul Norris(Director)inBrandon Kao(Director)inGary Pruden(Director)in
BoardCatherine Mohr(Director)in
Co-investorsMedVenture Partners, Inc.Golden SeedsLife Sciences Greenhouse Investments
Dalan develops vaccines that work with animals' natural immune defenses to protect against disease, with products including a USDA-approved honeybee vaccine and a shrimp vaccine in development.
AgTechBiotechClimate TechFoodTechAthens, US
Annette Kleiser(Founder & CEO)
Co-investorsAt One VenturesPrime Movers Lab
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.